KALV
KalVista Pharmaceuticals Inc.
$13.17
-$0.71(-5.12%)
37
Overall
--
Value
36
Tech
39
Quality
Market Cap
$682.06M
Volume
1.79M
52W Range
$7.30 - $17.28
Target Price
$30.00
EPS Estimates Overview
| Current Quarter | $-0.92 | Next Quarter | $-0.85 |
| Current Year | $-3.12 | Next Year | $-2.08 |
| QoQ Growth | +7.6% | YoY Growth | +33.3% |
| 3Y EPS CAGR | -3.2% | Target Price | $30.00 |
| Consensus | Buy | Upside | +127.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $13.17 | -5.1% | 1.79M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW